Key statistics dashboard for Agenus Inc. (AGEN). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
Agenus Inc. is a clinical-stage biotechnology firm operating globally, dedicated to the discovery and development of immuno-oncology therapies. The company's innovative technological arsenal includes Retrocyte Display, a sophisticated antibody expression platform designed to identify fully human and humanized monoclonal antibodies, alongside other proprietary display technologies.
Stock Data
| Price | $7.21 |
| Market Cap | $300M |
| Beta | 1.61 |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| Dividend Yield | 0.00% |
Related companies: ABOS · FATE · HURA · INO · IRD · PLRX · SEER
Explore sector: Healthcare · Biotechnology
More sections of AGEN: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks